Foraging activity is reduced in a mouse model of depression

Neurotoxicity Research

Volumn 25, Issue 3, 2014, Pages 235-247

  Yang, C R ^a   Zhang, Z G ^a   Bai, Y Y ^a   Zhou, H Fiona ^b   Zhou, L ^a   Ruan, C S ^a   Li, F ^c   Li, C Q ^c   Zheng, H Y ^d   Shen, L J ^a   Zhou, X F ^a,b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c Central South University   (China)

^d SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti depressant; Decision making; Depression; Foraging activity; GFAP

Indexed keywords

BRAIN PROTEIN; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; FLUOXETINE; GLIAL FIBRILLARY ASSOCIATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC UNPREDICTABLE MILD STRESS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL MOUSE; FORAGING BEHAVIOR; FORCED SWIM TEST; MALE; MENTAL STRESS; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST; VALIDATION PROCESS;

ANIMALIA; MUS; RODENTIA;

ANIMALS; ANTIDEPRESSIVE AGENTS; APPETITIVE BEHAVIOR; BODY WEIGHT; CEREBRAL CORTEX; CHRONIC DISEASE; CLOZAPINE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; FLUOXETINE; FREEZING REACTION, CATALEPTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84896038532     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9411-6     Document Type: Article

References (62)

1. Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ, Radulovic J, Churchill GA, Redei EE (2012) Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 17(1):49-61
2. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15(5):501-511
3. Barbano MF, Cador M (2006) Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs. Neuropsychopharmacology 31(7):1371-1381
4. Bardgett ME, Depenbrock M, Downs N, Points M, Green L (2009) Dopamine modulates effort-based decision making in rats. Behav Neurosci 123(2):242-251
5. Beats BC, Sahakian BJ, Levy R (1996) Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 26(3):591-603 (Pubitemid 26142501)
6. Berg C, Backstrom T, Winberg S, Lindberg R, Brandt I (2013) Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus. PLoS ONE 8(1):e55053
7. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137-151 (Pubitemid 43151600)
8. Bett D, Allison E, Murdoch LH, Kaefer K, Wood ER, Dudchenko PA (2012) The neural substrates of deliberative decision making: contrasting effects of hippocampus lesions on performance and vicarious trial-and-error behavior in a spatial memory task and a visual discrimination task. Front Behav Neurosci 6:70
9. Blokland A, Lieben C, Deutz NE (2002) Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16(1):39-49 (Pubitemid 34273072)
10. Bowley MP, Drevets WC, Ongur D, Price JL (2002) Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 52(5):404-412 (Pubitemid 35266731)
11. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62(4):479-493
12. Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT (2002) Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J Neurol Neurosurg Psychiatry 73(5):556-560 (Pubitemid 35246811)
13. Day JJ, Jones JL, Wightman RM, Carelli RM (2010) Phasic nucleus accumbens dopamine release encodes effort- and delay-related costs. Biol Psychiatry 68(3):306-309
14. Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MF, Bannerman DM (2005) Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology 179(3):587-596 (Pubitemid 40674759)
15. Drott J, Desire L, Drouin D, Pando M, Haun F (2010) Etazolate improves performance in a foraging and homing task in aged rats. Eur J Pharmacol 634(1-3):95-100
16. Elliott R, Sahakian BJ, McKay AP, Herrod JJ, Robbins TW, Paykel ES (1996) Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med 26(5):975-989 (Pubitemid 26305998)
17. Elliott R, Zahn R, Deakin JF, Anderson IM (2011) Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 36(1):153-182
18. Ernst M, Paulus MP (2005) Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry 58(8):597-604 (Pubitemid 41568582)
19. Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33(8):1966-1979 (Pubitemid 351832587)
20. Gardner EL, Walker LS, Paredes W (1993) Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat. Psychopharmacology 110(1-2):119-124 (Pubitemid 23029437)
21. Hauber W, Sommer S (2009) Prefrontostriatal circuitry regulates effort-related decision making. Cereb Cortex 19(10):2240-2247
22. Henn FA, Vollmayr B (2005) Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 29(4-5):799-804 (Pubitemid 40755465)
23. Herrera-Ruiz M, Garcia-Beltran Y, Mora S, Diaz-Veliz G, Viana GS, Tortoriello J, Ramirez G (2006) Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 107(1):53-58 (Pubitemid 44056299)
24. Holm MM, Nieto-Gonzalez JL, Vardya I, Henningsen K, Jayatissa MN, Wiborg O, Jensen K (2011) Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 21(4):422-433
25. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455(7215):894-902
26. Kumar B, Kuhad A, Chopra K (2011) Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology 214(4):819-828
27. Kutiyanawalla A, Terry AV Jr, Pillai A (2011) Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depressionlike behaviors in mice induced by corticosterone treatment. PLoS ONE 6(10):e26153
28. Li F, Cao WY, Li MB, Xu Y, Zhang JW, Zhang JY, Luo XG, Dai RP, Zhou XF, Li CQ (2012a) A simple method for detection of food foraging behavior in the rat: involvement of NMDA and dopamine receptors in the behavior. Neuroscience 205:73-80
29. Li F, Li M, Cao W, Xu Y, Luo Y, Zhong X, Zhang J, Dai R, Zhou XF, Li Z, Li C (2012b) Anterior cingulate cortical lesion attenuates food foraging in rats. Brain Res Bull 88(6):602-608
30. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC (2009) Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. Eur Neuropsychopharmacol 19(11):796-805
31. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC (2011) Glia atrophy in the hippocampus of chronic unpredictable stress-induced depression model rats is reversed by electroacupuncture treatment. J Affect Disord 128(3):309-313
32. Luo DD, An SC, Zhang X (2008) Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res Bull 77(1):8-12
33. Malakoff D (2000) The rise of the mouse, biomedicine's model mammal. Science 288(5464):248-253
34. Mao QQ, Huang Z, Zhong XM, Feng CR, Pan AJ, Li ZY, Ip SP, Che CT (2010) Effects of SYJN, a Chinese herbal formula, on chronic unpredictable stress-induced changes in behavior and brain BDNF in rats. J Ethnopharmacol 128(2):336-341
35. Molina VA, Volosin M, Cancela L, Keller E, Murua VS, Basso AM (1990) Effect of chronic variable stress on monoamine receptors: influence of imipramine administration. Pharmacol Biochem Behav 35(2):335-340 (Pubitemid 20075574)
36. Murphy FC, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES, Sahakian BJ (2001) Decision-making cognition in mania and depression. Psychol Med 31(4):679-693 (Pubitemid 32421969)
37. Nicola SM (2010) The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior. J Neurosci 30(49):16585-16600
38. Pal A, Nayak S, Sahu PK, Swain T (2011) Piperine protects epilepsy associated depression: a study on role of monoamines. Eur Rev Med Pharmacol Sci 15(11):1288-1295
39. Peng YL, Liu YN, Liu L, Wang X, Jiang CL, Wang YX (2012) Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. J Neuroinflamm 9:75
40. Pollak DD, Rey CE, Monje FJ (2010) Rodent models in depression research: classical strategies and new directions. Ann Med 42(4):252-264
41. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327-336 (Pubitemid 8225714)
42. Pothion S, Bizot JC, Trovero F, Belzung C (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155(1):135-146 (Pubitemid 39119974)
43. Rajkowska G (2002) Cell pathology in mood disorders. Semin Clin Neuropsychiatry 7(4):281-292
44. Rajkowska G, Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord 6(3):219-233 (Pubitemid 46916253)
45. Renault J, Aubert A (2006) Immunity and emotions: lipopolysaccharide increases defensive behaviours and potentiates despair in mice. Brain Behav Immun 20(6):517-526 (Pubitemid 44550170)
46. Reus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J (2010) Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res Bull 81(6):585-589
47. Rushworth MF, Walton ME, Kennerley SW, Bannerman DM (2004) Action sets and decisions in the medial frontal cortex. Trends Cogn Sci 8(9):410-417 (Pubitemid 39179904)
48. Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 65(2):221-229
49. Salamone JD, Correa M, Mingote SM, Weber SM (2005) Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 5(1):34-41 (Pubitemid 40124532)
50. Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN (2009) Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behav Brain Res 201(1):216-222
51. Sartori Oliveira CE, Gai BM, Godoi B, Zeni G, Nogueira CW (2012) The antidepressant-like action of a simple selenium-containing molecule, methyl phenyl selenide, in mice. Eur J Pharmacol 690(1-3):119-123
52. Shen X, Xu GZ (2007) Effect of interleukin-1 beta on glutamine synthetase in rat retinal Muller cell under high glucose conditions. Zhonghua Yan Ke Za Zhi 43(8):744-749
53. Shen K, Kalwarowsky S, Clarence W, Brunamonti E, Pare M (2010) Beneficial effects of the NMDA antagonist ketamine on decision processes in visual search. J Neurosci 30(29):9947-9953
54. Stahl SM (2002) The psychopharmacology of energy and fatigue. J Clin Psychiatry 63(1):7-8
55. Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27(15):4201-4209 (Pubitemid 46597167)
56. Swiergiel AH, Dunn AJ (2007) Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 86(4):651-659 (Pubitemid 46829318)
57. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ (2006) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60(1):66-73
58. Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83(3):482-504
59. Walton ME, Croxson PL, Rushworth MF, Bannerman DM (2005) The mesocortical dopamine projection to anterior cingulate cortex plays no role in guiding effort-related decisions. Behav Neurosci 119(1):323-328 (Pubitemid 40279522)
60. Walton ME, Groves J, Jennings KA, Croxson PL, Sharp T, Rushworth MF, Bannerman DM (2009) Comparing the role of the anterior cingulate cortex and 6-hydroxydopamine nucleus accumbens lesions on operant effort-based decision making. Eur J Neurosci 29(8):1678-1691
61. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52(2):90-110
62. Zhang HJ, Sun D, Lee TM (2012) Impaired social decision making in patients with major depressive disorder. Brain Behav 2(4):415-423